Uppdrag | 18 Apr 2024

Setterwalls advises BrainCool in connection with a rights issue

Responsive image
Setterwalls advises BrainCool AB (publ), listed on Nasdaq First North Growth Market, in connection with a rights issue of shares.
BrainCool is an innovative medical technology company that develops, markets and sells leading medical cooling systems for indications and areas with significant medical added value in healthcare. BrainCool is headquartered in Lund, Sweden. Through the rights issue, BrainCool may receive issue proceeds of approximately SEK 85.8 million before issue costs.

Contact:

Ola Grahn, Gustav Johansson, Elsa Economou Olsson, Erik Olshov, Jonathan Lindström

Practice areas:

Equity Capital Markets, Corporate law, Life Sciences

  • This field is for validation purposes and should be left unchanged.

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.

Related news

Setterwalls has advised Out of Home AB (publ) in connection with the acquisition of Smålands Skafferi AB

Uppdrag | 14 Nov 2024

Setterwalls has advised Out of Home AB (publ) in connection with the acquisition of Smålands Skafferi AB

Read more
The Listing Act – The European Union’s new legislative package aimed to facilitate for companies listing shares and companies acting in a listed environment

Article | 14 Nov 2024

The Listing Act – The European Union’s new legislative package aimed to facilitate for companies listing share...

Read more
Setterwalls advises Crunchfish in connection with a rights issue

Uppdrag | 06 Nov 2024

Setterwalls advises Crunchfish in connection with a rights issue

Read more
Load more